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Abstract
Purpose: The purpose of the study was to present the quantitative and qualitativeevaluation of newly incorporated photon optimizer (PO) versus previously wasused independent dose volume optimizer (DVO) for intensity modulated radiationtherapy (IMRT) and progressive resolution optimizer (PRO) for Rapid-arc/volumetric modulated arc therapy (VMAT) in version 13.5 of Eclipse treatmentplanning system (ETPS). Methods: We accomplished this study with the help ofcylindrical virtual phantom created in the ETPS. Six individual phantoms study sets(PSS) were generated and different material density value was assigned in order toevaluate the behavior optimizers in the presence of tissue heterogeneity. Severalindependent plans were generated for IMRT and Rapid-arc by changing optimizermodule PO, DVO, and PRO for 6 MV, 15 MV flattened beam and 6 MV-flatteningfilter free (FFF) beam. Results: The self-governing evaluations of PO versus DVOfor IMRT plan and PO versus PRO for Rapid-arc/VMAT plans were performed. Weestimated and compared various distinct parameters such as maximum dose,minimum dose, mean dose, conformity index (CI), quality index (QI), homogeneityindex (HI), integral plan monitor unit (MU) and dose volume histogram (DVH). Thepercentages of the average variation over all PSS and beam energy between POversus DVO optimized plan quality parameters such as planning target volume(PTV) maximum, minimum, mean doses, CI, QI and HI were 0.23%, 1.67%, 0.09%,20.4%, 0.77% and 0.52% , respectively, whereas for PO versus PRO were 1.18%,3.38%, 0.19%, 8.11%, 2.78%, and 1.28%, respectively. Conclusion: The resultspresented in this study showed that PO generates plans with better quality inshorter time compared to DVO and PRO for both IMRT and Rapid-arc/VMAT,respectively.
Keywords: Optimization, Dose Volume Optimizer, Progressive ResolutionOptimizer, Photon Optimizer, IMRT, Rapid-arc
1. IntroductionEfficient delivery of intensity modulated radiationtherapy (IMRT) requires the concept of “PhysicalOptimization”.1-2 Over the due course of time, numerousoptimization algorithms3 have been  developed forIMRT planning optimization. Distinct objective functionswere used to attain IMRT planning goal. Since, differentmathematical properties of the objective function forbidto use single optimization algorithm. Thereby, separate
optimization algorithms used as per the objectivefunction to achieve desired goal. The current practicalapproach of all optimizations based on an iterativeoptimization scheme. Previously, based on deterministicand conjugate gradient approachs4, several algorithmssuch as steepest decent, Newton Method, StochasticMethod, Simulated Annealing, Boltzman Annealing andFast Simulated Annealing were developed to control
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various parameters. Over the period direct apertureoptimization (DAO)5 was developed for simultaneousoptimization of beam weight and shape of the aperture,in order to  add more degree of freedom to aperturebased planning approach. Similarly, several optimizerssuch as direct machine parameter optimizer (DMPO)6,plan geometry optimizer (PGO), multi resolution dosecalculation (MRDC), dose volume optimizer (DVO),progressive resolution optimizer (PRO) and photonoptimizer (PO) were developed for various objectives inIMRT and Rapid-arc.Recently, Varian Medical System has incorporated PO asa new dose calculation optimizer for both static gantryIMRT optimization as well as Rapid-arc/volumetricmodulated arc therapy (VMAT)7 optimization in Eclipsetreatment planning system (ETPS) version_13.5. In theolder versions (lower than 13.5), ETPS is using separateoptimizer DVO for IMRT whereas, PRO for Rapid-arc/VMAT optimization. PO is supporting all featurescurrently supported by the DVO and PRO except for DVO“field weight optimization” and “minimize dose”optimization parameter. A new feature with PO isconvenient for both of static IMRT as well as Rapid-arcprovides an approximation of dose distribution shownin the 2D view during optimization. Optimizationobjectives for generalized equivalent uniform dose(gEUD) are available for IMRT and VMAT plans.Automatic normal tissue objective (NTO), mean doseobjectives and second source inhomogeneity correctionare now supported for static gantry IMRT optimization.PO also supports for Siemens Modulated (mARC)optimization for machine equipped with 160 MLC,VMAT for Elekta Synergy, AgilityTM and VersaHD. As thePO is included as a new calculation model, PO supportssame beam configuration data as of DVO or PRO. Thisstudy has been mainly focused on an extensivecomparison of recently incorporated PO optimizerversus previously being used DVO and PRO for IMRTand Rapid-arc/VMAT optimization respectively.
2. Methods and MaterialsWe created a volume of 21.195 × 103 (∏r3h, h = 30 cm, r= 30 cm) cylindrical virtual phantom  in Eclipsecontouring workstation by assigning the materialdensity of 1.0 gm/cm3 corresponding to HU = 0 values ofwater. Six distinct phantom study sets (PSS) werecreated consisting planning target volume (PTV = 344.0cm3) encompassing organ at risk (OAR = 40.0 cm3) of thesimilar shape and volume over all PSS. Further differentstructures were created around PTV in phantom byassigning various densities in order to evaluate theeffect of inhomogeneity and to reproduce human mediaon homogeneous phantom in each PSS. The ellipticalshape of a PTV encompassing circular shape of OAR wasthen drawn into the center of the phantom. Illustrationof each of PSS given as follows. The PSS 1st were createdonly with PTV encompassing the OAR on homogeneous
phantom. The PSS 2nd consisting of bone density ρ2 =1.5574 gm/cm3 corresponds to HU = 900 and air cavitywith HU = -1000 inside the PTV. PSS 3rd containednumber of bony structure are less in number of densityρ3= 1.4373 gm/cm3 corresponds to HU = 700, whereasair cavity structure with HU = -1000 are more in numberoutside the PTV. PSS 4th were created by including morenumber of bony structure of density ρ4= 1.5273 gm/cm3correspond HU = 850 whereas less air cavity structurearound the PTV. PSS 5th and PSS 6th were created withboth PTV and OAR entirely covered with an air cavity ofHU = -1000 and bone density of ρ6 = 1.6146 gm/cm3corresponds to HU = 1000, respectively. Transverseviews of each of the study set is shown in Figure 1.
Figure 1: Different cylindrical phantom study sets (PSS).Phantom study sets 1- 6 embedded with different materialdensity such as air, bone to represent the heterogeneousphantom.This study was accomplished for both IMRT andRapid-arc/VMAT technique by creating individual planfor independent PO versus DVO and PO versus PRO forIMRT and Rapid-arc/VMAT, respectively, in ETPS(Version 13.5, Varian Medical System). In order toperform comparative evaluation of IMRT and Rapid-arc/VMAT plans with their different optimizer, wegenerated plan for 50 Gy/25#, 2Gy dose per fractionwith 6 MV flattened, 6 MV flattening filter free (FFF)lower energy and 15 MV higher energy beam. We usedanalytical anisotropic algorithm (AAA) to carry outfinal dose calculation. All the plan specific parametersuch as energy, dose prescription, gantry angle in IMRTplan, Arc-geometry in Rapid-arc/VMAT plan, penumbramargin and optimization parameter such as upper doseobjective; lower dose objective, mean dose objective,normal tissue objective (NTO) and priority values werekept similar while optimizing the plan with PO versusDVO and PRO for IMRT and Rapid-arc/VMATrespectively. According to Radiation Oncology TherapyGroup (RTOG) protocol, minimum plan passing  criteriafor target volume is that 95% of target volume shouldreceive the 95% prescription dose and an OAR shouldnot exceed a maximum dose of 45 Gy. Initially, allobjective parameters were chosen in a way , to achievethe plan-passing criteria with PO for both IMRT andRapid-arc/VMAT plan. Once we achieved the desiredgoal, then without changing any of  these parameters,other plans were generated by changing the optimizermodule DVO for IMRT and PRO for Rapid-arc/VMATrespectively. Entire set of 72 plans were generated toaccomplish the study. Individual 36 plans for each of
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IMRT plan were optimized with PO versus DVO andRapid-arc /VMAT plan were optimized with PO versusPRO.
2.1. Optimization algorithmAn optimization algorithm determines the optimal fieldshape and intensity by iteratively conforming dosedistribution to the desired objectives until an optimumsolution is reached. The algorithm optimizes a planbased on dose-volume objectives. Optimizationalgorithm uses an objective function to optimize planand to evaluate its quality. The objective function is thesum of the dose-volume and other user-definedobjectives. Each optimization objective has its own fourparameters such as an optimization priority (p), dosegoalUpper (Maximum) limit, Lower (Minimum) limit andmean dose as a function of dose-volume conjunctioncriteria. A structure with (n) points (i) and (m)optimization objectives obtains a total cost value as8:
where, dosei = Dose at Point idosegoal = Prescribe dose or Upper limitThe objective weighting (W= Objectiveweight) is derivedfrom the heuristic power law formula. The cost functionsfor an objective j are only taken into account for therange of voxels that violate the assigned dose volumecriteria. Similarly, multi-resolution dose calculationalgorithm (MRDC) enables fast dose estimation insidethe DVO, PRO and PO. The high speed of the MRDCalgorithm allows optimization algorithms to perform fulldose computation during each iteration. MRDC dose isbased upon a convolution superposition principle, and ituses 3D convolution scatter computation.9 Optimizer POand PRO both taken into account for an air cavitycorrection, but DVO does not correct dose for air cavity.
2.2. Dose volume optimizer (DVO_13.5.35)DVO algorithm is used in Eclipse IMRT to determineoptimal field shape and intensity.10 In each field; DVOlays the fluence to target projection with 5 mm margin.Then the created fluence object is expandedsymmetrically to field isocenter by adding the fluencepixel to zero values. Maximum size of the fluence objectsis 40×40 cm. The dose optimization algorithm performsthe optimization as a minimization problem usingsimple gradient optimization. Initially, all the fluencesare zero and alternatively; the fluence from a previousoptimization is used as the initial guess. Theoptimization modifies these fluences for each iterationand calculates the dose from the fluence after eachmodification. Once the doses at the points of the cloudsrepresenting the patient volumes are evaluates; theobjectives at the points and the derivatives of the pointobjectives are calculated. The cost functions areevaluated at each point in each structure. The
derivatives of the cost at each point are back-projectedto the fluences, forming the gradient. Optimization usesthe gradient search method. The gradient search isdivided into two phases; gradient evaluation and linesearch method. Gradient evaluation generates thegradient direction and gradient length. Whereas; linesearch evaluates the objectives on a line segment alongthe gradient and finds the minimum along the linesegment.The DVO algorithm can use calculated plan dose as anintermediate dose when optimizing a plan. The DVOalgorithm calculates the difference between theintermediate dose and the first round optimizationresult and uses this difference to compensate theoptimal result in the consequent iterations. If a newintermediate dose is calculated after the firstoptimization iteration, the difference is calculated againand it  is used to compensate subsequent iterations.Using an intermediate dose is particularly useful if theDVH calculated during optimization deviates from theDVH produced during dose calculation, for example,when there is a lot of heterogeneity in the volume to betreated. Optimization in Eclipse with the DVO wassubjected to Optimization convergence errors(OCEs).11-14 Error is primarily due to the dosecalculation for lateral scatter, dose calculation in thebuild-up region and modeling of transmission. Dosecalculation errors are present near electronicdisequilibrium region.Projected DVO describes the intensity of the radiationfield. That is at each fluence pixel value indicates howlong (In relative terms) a leaf must be open at theposition. DVO can produce the large intensity value ofone with open field. In DVO, larger value can exist morethan the one. The pixel value normalizes so that theoptimizer’s DVO internal dose calculation has 100%dose at DVO’s reference geometry. This means; it’spossible that some intensity pixel has  value greaterthan one depending on field setup.
2.3.Progressive resolution optimizer (PRO_
13.5.35)PRO is used to optimize MLC aperture of arc  field.Progressive multi-resolution strategies are used to getthe finer resolution starting with crude approximation.15PRO allows Rapid-arc/VMAT fields  to avail theDynamic MLC, variable dose rate and variable gantryspeed to produce optimal dose distribution.16 The PROalgorithm generates a sequence of 178 control points,which define MLC leaf positions and MU/deg as afunction of gantry angle. The initial conditions for thePRO algorithm are to defined control points thatrepresent each Rapid-arc/VMAT field. The algorithmsare using a multi-resolution approach to optimize theplan. Optimization process goes through fourmulti-resolution levels, in which number of controlpoints and dose calculation sector increase at each level,
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progressively from 10 to 178.16 This means that; thedose is modeled using first a lower number of dosecalculation segments that are distributed evenly in eachfield. The number of dose calculation segments increaseswhen moving from one multi-resolution level to another.The dose in a dose calculation segment is calculatedfrom the combined fluence through the MLC aperturesat the control points located within a certain sector ofthe arc. Leaf motions are model by interpolating leafpositions between the control points. Leaf tongues aremodel by modifying the MLC aperture outline to accounteffectively for the tongue-and-groove effect. The angularresolution of the dose calculation segments gets moreaccurate as the optimization progresses, and inconsequence, the dose gets more meticulous. Thenumber of control points remains the same during thewhole optimization.At the beginning of the optimization, the initial MLCshapes are conform to the targets, and the initial doserates are equal for all dose calculation segments. TheMLC shapes and dose rates of the different controlpoints in the VMAT field are optimizes. During the initialphases of the optimization, bigger adjustments are madein leaf sequencing. The size of these adjustmentsdecreases as the optimization progresses through thelevels. During the optimization, the algorithm proceedsthrough multi-resolution levels progressively increasingthe accuracy of the dose calculation. At the firstmulti-resolution level, only a few dose calculationsegments are used to model the dose, and eachmulti-resolution level contains progressively more dosecalculation segments. The angle between the resultingdose calculation segments on the last multi-resolutionlevel- 4 will be approximately 2°- 4°. The total number ofdose calculation segments used depends on the span ofthe arc. Inside each multi-resolution level, there areseveral steps. Each step has its own internal calculationparameter set. The optimization allows somediscontinuities in the delivery during early phases of theoptimization, and decreases the size of thediscontinuities stepwise as the optimization progresses.The number of steps in different multi-resolution levelsvaries. Due to the nature of the optimization process, thePRO algorithm is not fully deterministic. Therefore,successive optimizations with the same constraints mayyield different results.Air cavity correction has been  incorporated in newPRO optimizer, which applies a finer resolution in theinternal dose calculation grid during optimization whenair equivalent densities are identified.9 PRO providessome additional new features including air cavitycorrection, intermediate dose option and jaw tracking.14Air cavity correction is an additional parameter forfine-tuning the inhomogeneities correction by applyingfiner resolution to calculate the scatter component.
Figure 2: Representation of point cloud structure model inDVO and PRO algorithm.
Figure 3: Representation of point cloud structure model inPO algorithm.
2.4. Photon optimizer (PO_13.5.35)The photon optimization algorithm PO optimizes staticfield IMRT, Rapid-arc/VMAT and Siemens mARC plan.The PO combines the previous optimization methodsused for static field IMRT and arc field IMRT with DVOand PRO respectively. The main difference betweenthe PO algorithm and the earlier optimization algorithmsDVO and PRO is that the earlier optimization algorithmsused a point cloud model for defining structures.  POalgorithm uses a new structural model, wherestructures, DVH calculation and dose sampling aredefined spatially by using one single matrix over theimage. The voxel resolution of the matrix is using fixedvalues of 1.25 mm, 2.5 mm or 5 mm. This resolutiondefines the planar X and Y resolution in the slices. The Zresolution orthogonal to the slices is a function ofchoosing resolution and the slice spacing. For example, ifthe original image has a slice resolution of 1 mm × 1 mmand a slice spacing of 8 mm and the user has defined theoptimum resolution to be 2.5 mm, then the optimizeruses the matrix of 2.5 mm × 2.5 mm × 4 mm. This matrixdefines the locations of the structures and the samplingof the dose, and it substitutes the previously used pointclouds. The DVH for the structure is evaluated usingvolume weights defined for each voxel.
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The volume weight of the voxel defines the ratio of theoriginal structure segment inside the voxel. For smallstructures, the DVH is super-sampled from the dosematrix to make the DVH look smoother. Figures2 and 3represents a point cloud structure model for theDVO/PRO and PO respectively, which define the voxelsthat represents the structure while optimization. Thesesamples also represent the place where the total dosefrom each field is evaluated.
2.5. Plan quality parameters
2.5.1. Conformity index (CI)CI is a measure of conformity of isodose encompassingthe target. CI was developed as an extension ofsection-by-section dosimetric analysis and dose volumehistogram. RTOG propose the routine evaluation of anexternal beam treatment plan based on severalparameters such as reference isodose value of thetreatment plan, reference isodose volume and it can bedefined as the ratio of target volume covered byreference volume, to the target volume.17 CImathematically defined as,Conformity IndexRTOG = (VRI /TV) (2)where,VRI = Target Volume covered by reference isodose.TV = Target Volume.A CI  equal to 1 corresponds to ideal conformation. A CIgreater than 1 indicates that the irradiated volume isgreater than the targetted volume and it includeshealthy tissue. Whereas, if estimated CI value is less than1 it indicates the target volume is partially irradiated.
2.5.2. Quality index (QI)RTOG defines QI to investigate the quality of treatmentplans. According to RTOG, depending on 90% and 80%of isodose covering the target volume, the quality ofirradiation can be estimated. If the 90% isodose coversall clinical and pathological target volumes, treatment isconsidered to comply with protocol. If 80% of isodosecovers all the clinical and pathological target volume, theprotocol violation considers as minor. On the otherhand, if 80% of isodose not covers the all of the clinicaland pathological target volume, the protocol violationconsidered to be major.17 QI mathematically defined as,Quality IndexRTOG = (Imin/ RI) (3)where, Imin= Minimum isodose around the target.RI = Reference isodose.
2.5.3. Homogeneity index (HI)HI is defined as the ratio of the maximum isodose to thereference isodose in the target.17 HI is mathematicallydefined as,Homogeneity IndexRTOG = (Imax/RI) (4)where,
Imax= Maximum dose in the target.RI = Reference isodose.Ideal HI index considered to be 1. If the homogeneityindex is ≤ 2 treatments are considered to be incompliance with the protocol. If this index is between 2to 2.5 then the protocol violation is considered as minor,but when the index  exceeds 2.5 then protocol violationconsidered to be major, but nevertheless considered tobe acceptable.
3. ResultsResults consist of averaged parameters were estimatedover six distinct study sets and each of the individualstudy sets are presented. Plan optimized with POoptimizer versus DVO for IMRT and PRO for Rapid-arcwere compared, respectively. Evaluated parameterscomprise  the PTV (maximum, minimum, mean) dose,OAR (maximum, mean) dose, conformity index, qualityindex, homogeneity index, PTVD95%Vol, OARD100%Vol,OARD90%Vol, OARD80%Vol, OARD50%Vol, integral plan MU andtime taken by the optimizer to optimize the plan.Variation in these plan parameters optimized with POversus DVO for IMRT were found marginally more thana plan optimized with PO versus PRO forRapid-arc/VMAT plan. Optimization time was found lesswith PO compared to other DVO and PRO for both IMRTand Rapid-arc/VMAT plans, respectively.
Figure 4: DHV comparison of 6 MV IMRT plan with POagainst DVO.
3.1. Comparison of IMRT plan with PO Vs DVOTable 1 summarizes the  comparative result of IMRTplans optimized with PO versus DVO. The averagevariation in most of the above parameters for planoptimized with PO in comparison with DVO for IMRTcreated over six phantoms (PSS1-to-PSS6) study setsand 6 MV; 6 MVFFF and 15 MV energies were foundminimal. The percentages of the average variationbetween PO versus DVO optimized plan parameters  ofPTV maximum, minimum, and mean doses were found0.23%, 1.67% and 0.09%, respectively, whereas OARmaximum and mean doses were 0.84% and 1.84%,respectively. Similarly, variations in estimated values for
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CI, QI, HI, PTVD95%Vol,OARD100%Vol, OARD90%Vol, OARD80%Vol,OARD50%Vol and  integral plan MU were found 20.4%,0.77%, 0.52%, 0.63%, 9.57%, 3.54%, 2.46%, 1.95% and62, respectively.PTV maximum doses over the all six PSS were foundmarginally less in the plan optimized with PO than DVO,whereas PTV minimum dose was found more with POthan DVO. This variance found monotonically increasingwith energy. Insubstantial variations were observed in amean dose between the plan optimize with PO and DVO.These variations in OAR side found more than PTV.Similarly, CI and QI values were found more in the planoptimize with PO than DVO. Average variation in CIvalues over six distinct PSS between PO and DVO were19.89%, 18.57%, and 22.75% whereas, QI variationwere 0.57%, 1.01%, 0.74% for 6 MV, 6 MVFFF and 15MV energies, respectively. Planned MU was found to besignificantly less in the plan optimized with PO thanDVO.  The average variations over six PSS were 52 MU,99 MU, and 35 MU for 6MV, 6MVFFF and 15MV,respectively. Optimization time taken by DVO isremarkably more than PO. Percentage of average andmaximum optimization time differences found was 9.2%and 21.3%, respectively. Tables 2, 3 and 4 summarizedata for each individual plan with OP versus DVO overthe six PSS.
Figure 5: DVH comparison for 6 MVFFF IMRT plan with POagainst DVO.
Figure 6: DVH comparison of 15 MV IMRT plan with POagainst DVO.
3.2. Comparison of Rapid-arc plan with PO Vs PRO:Table 5 summarizes the  comparative result ofRapid-arc plans optimized with PO versus PRO. Theaverage variation in most of the above parameters forplan optimize with PO in comparison with PRO forRapid-arc created over six phantoms (PSS1-to-PSS6)study sets as well as 6 MV, 6 MVFFF and 15 MV energieswere found to be significant. The percentages of averagevariation between PO and PRO optimized planparameters such as PTV maximum, minimum, and meandoses were found 1.18%, 3.38% and 0.19%,respectively. The OAR maximum and mean doses were1.76% and 2.86%, respectively. Similarly, variations inestimated values for CI, QI, HI, PTVD95%Vol, OARD100%Vol,OARD90%Vol, OARD80%Vol, OARD50%Vol and integral plan MUwere found to be 8.11%, 2.78%, 1.28%, 2.33%, 9.36%,5.57%, 4.6%, 4.46% and 20, respectively.PTV maximum and minimum dose follow same analogyas in IMRT plan. In contrary to IMRT plan, the variancefound as monotonically decreasing with energy.Insubstantial variations were observed in mean dosebetween plans optimize with PO and PRO. However, thisvariation was found more in Rapid-arc than in IMRTplan. These variations were found to be more for theOAR compared to the PTV. The average variation in CIvalues over six distinct PSS between PO and PRO were8.88%, 9.15%, 6.31%, whereas QI variations were 3.3%,2.79%, and 2.25% for 6 MV, 6 MVFFF and 15 MVenergies, respectively. Variation in CI and QI values wereless than a factor of two in Rapid-arc plan optimizedwith PO versus PRO than IMRT plan optimized with POversus DVO. Remarkable variations were observed inplaned MU between plans optimized with PO versusPRO that is in contrary to IMRT plan optimized with POversus DVO. Planed MU was found to be significantlymore in plan optimized with PO than PRO. However,these differences were found more in IMRT planoptimized with the PO versus DVO thanRapid-arc/VMAT optimized with the PO versus PRO.These average variations over six PSS were found to be22 MU, 22.5 MU and 16 MU for 6MV, 6MVFFF and 15MV,respectively. Optimization time taken by PRO ismarginally more than the PO. Percentage of average andmaximum optimization time differences found were1.02% and 4.8%, respectively. Tables 2, 3, and 4summarize data for each individual plan with OP versusPRO over the six PSS.
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Table 1: Average percentage difference for IMRT plan parameters between PO and DVO.Parameters 6 MV 6 MVFFF 15 MV %AveragePTV Min Dose (%) 1.18 1.75 2.08 1.67PTV Max Dose (%) 0.18 0.18 0.33 0.23PTV Mean Dose (%) 0.08 0.07 0.13 0.09OAR Max Dose (%) 0.93 0.97 0.63 0.84OAR Mean Dose (%) 1.73 1.88 0.82 1.48CI (%) 19.89 18.57 22.75 20.40QI (%) 0.57 1.01 0.74 0.77HI (%) 1.15 0.13 0.28 0.52Plan MU 52.33 99.16 35.00 62.0*PTVD95% Vol. (%) 0.39 0.49 0.95 0.60*OARD100%Vol. (%) 9.39 9.84 9.55 9.57*OARD90%Vol. (%) 3.83 4.31 2.50 3.54*OARD80%Vol. (%) 2.12 3.72 1.56 2.46*OARD50%Vol. (%) 2.36 2.77 0.73 1.95Note: *PTVD95%Vol, *OARD100%Vol,*OARD90%Vol, *OAR80%Vol, *OARD50%Volmeandose received to 95%,100%, 90%, 80% and 50%volume of PTV and OAR respectively. All the table values are given in % difference between PO and DVO; CI = ConformityIndex; QI = Quality Index; HI = Homogeneity Index
Table 2: Estimate parameter of 6 MV energy IMRT and Rapid-Arc plan with PO versus DVO and PRO, respectively, over thedistinct phantom study sets (PSS).Study-Sets PSS1 PSS2 PSS3 PSS4 PSS5 PSS6IMRT-Parameter PO DVO PO DVO PO DVO PO DVO PO DVO PO DVOPTV Min Dose (%) 92 90.2 92.2 90.4 91.6 89.8 92.1 90.3 91.6 89.6 92.1 90.4PTV Max Dose (%) 101.9 102 102.5 102.8 101.9 102.1 101.9 102.1 102 102.1 101.9 102.1PTV Mean Dose (%) 101.6 101.7 101.7 101.6 101.6 101.7 101.6 101.7 106 106 101.7 101.6OAR Max Dose (%) 83 82 83 82 83 82 83 82 82.8 82.1 83 82OAR Mean Dose (%) 76 74.4 75.7 74.4 75.9 74.4 76 74.4 74.3 77.2 76.2 74.7CI 1.31 1.1 1.33 1.1 1.32 1.1 1.32 1.096 1.29 1.084 1.296 1.105QI 0.996 0.994 0.989 0.978 0.989 0.984 1 0.994 0.989 0.984 0.989 0.984HI 1.07 1.13 1.074 1.073 1.071 1.073 1.069 1.07 1.068 1.07 1.071 1.07Plan MU 703 756 695 755 705 757 697 745 650 686 717 780*PTVD95%Vol. (%) 98.01 97.66 98.03 97.62 98.07 97.65 98.05 97.66 98.12 97.6 97.9 97.66*OARD100%Vol. (%) 61.95 56.4 61.98 56.86 60.77 56.54 62.34 56.17 57.43 49.4 62.19 57.22*OARD90%Vol. (%) 73.44 70.79 73.03 70.74 73.1 70.79 73.43 70.79 69.47 65.15 75.71 71.09*OARD80%Vol. (%) 74.04 71.66 73.6 71.62 73.88 71.7 74 71.66 71.76 68.75 74.31 72.09*OARD50%Vol. (%) 75.68 73.8 75.33 73.74 75.52 73.84 75.63 73.75 74.13 72.17 75.86 74.17RapidArc Parameter PO PRO PO PRO PO PRO PO PRO PO PRO PO PROPTV Min Dose (%) 90.4 85.6 90.1 87.1 87.3 83.5 85.6 81.4 85.6 82.2 87.5 82PTV Max Dose (%) 101.9 106.1 104.5 106.5 106.2 108.1 105.9 106.6 107 106.1 105.4 107.4PTV Mean Dose (%) 100.4 100.4 100.3 100.3 99.2 100.5 100.3 100.5 100.3 100.6 100 100.5OAR Max Dose (%) 85.7 88.1 86 88.1 87.3 88 86.8 88.6 87.7 88.2 85.9 88.9OAR Mean Dose (%) 70.7 76.8 71.3 76.6 73.8 75.5 73.5 77 70 73.1 73.3 75.3CI 1.15 1.15 1.19 1.05 1.1 1.01 1.1 1 1.07 0.99 1.09 1.01QI 0.984 0.963 0.98 0.95 0.96 0.93 0.94 0.9 0.92 0.9 0.94 0.91HI 1.09 1.1 1.09 1.1 1.09 1.1 1.19 1.11 1.09 1.1 1.08 1.12Plan MU 511 491 518 496 508 485 504 491 473 427 536 527*PTVD95%Vol. (%) 96.68 95.19 97.36 95.54 96.5 94.7 95.04 93.32 96.34 94.53 96.63 94.32*OARD100%Vol. (%) 42.2 53.53 41.93 51.65 47 43.6 39.34 46.27 36.58 40.1 43.25 42.24*OARD90%Vol. (%) 55.8 65.38 57.04 65.33 62.27 62.4 59.74 66.4 52.6 55.96 59.81 61.14*OARD80%Vol. (%) 62.1 71.04 62.7 70.5 67.1 68.5 67.19 70.64 58.75 62.99 76.14 78.95*OARD50%Vol. (%) 73.3 79.48 73.79 79.15 75.71 78.8 76.18 79.55 73.49 77.45 79.15 81.42
Note: *PTVD95%Vol, *OARD100%Vol, *OAR90%Vol, *OAR80%Vol and *OAR50%Vol mean dose received to 95%, 100%, 90%, 80% and50%  volume of PTV and OAR respectively. % sign indicates table values are given in % dose of prescribe dose of theirrespective plan; CI = Conformity Index; QI = Quality Index; HI = Homogeneity Index
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Table 3: Estimate parameter of 6 MVFFF energy IMRT and Rapid-Arc plan with PO versus DVO and PRO, respectively, overthe distinct phantom study sets (PSS).Study-Sets PSS1 PSS2 PSS3 PSS4 PSS5 PSS6IMRT-Parameter PO DVO PO DVO PO DVO PO DVO PO DVO PO DVOPTV Min Dose (%) 91.8 90.1 92.1 90.3 91.5 89.7 92 90.2 91.3 89.4 92 90.5PTV Max Dose (%) 101.9 102.1 102.4 102.8 102 102.1 101.9 102.1 102.1 102.1 102 102.5PTV Mean Dose (%) 101.5 101.6 101.5 101.5 101.5 101.6 101.5 101.6 101.5 101.6 101.7 101.6OAR Max Dose (%) 83.1 82 83 82.1 83 82.1 83 82 82.8 82.1 83.1 82OAR Mean Dose (%) 76.2 74.4 76.1 74.3 76.1 74.3 76.2 74.2 74.4 72 76.4 74.7CI 1.29 1.09 1.31 1.09 1.3 1.09 1.3 1.09 1.3 1.08 1.29 1.10QI 0.99 0.98 0.989 0.978 0.989 0.978 1 0.98 0.989 0.984 0.99 0.98HI 1.07 1.07 1.075 1.074 1.071 1.073 1.071 1.07 1.071 1.07 1.071 1.07Plan MU 800 881 785 877 803 885 789 864 607 792 828 910*PTVD95%Vol. (%) 97.91 97.66 97.93 97 97.98 97.64 97.95 97.66 98.09 97.58 97.82 97.66*OARD100%Vol. (%) 61.9 55.9 61.38 56.41 60.38 55.88 62.04 55.64 56.61 48.14 61.78 56.46*OARD90%Vol. (%) 73.65 70.74 73.48 70.82 73.36 70.63 73.65 70.56 69.31 64.86 74.03 71.05*OARD80%Vol. (%) 74.35 71.67 74.13 71.72 74.2 71.55 74.28 71.45 71.76 68.86 74.6 71.93*OARD50%Vol. (%) 75.95 73.83 75.74 73.85 75.82 73.73 75.89 73.67 74.31 71.93 76.1 74.19RapidArc Parameter PO PRO PO PRO PO PRO PO PRO PO PRO PO PROPTV Min Dose (%) 90.4 85.6 86.2 80.7 86.4 81.2 84 78.7 83.6 84 84.7 81.9PTV Max Dose (%) 104.8 106.5 107.3 107.8 105.7 107.8 105.6 108.7 106.3 106.9 105.9 106.8PTV Mean Dose (%) 100.2 100.4 100.4 100.4 100.4 100.6 100.5 100.6 100.4 100.6 100.4 100.5OAR Max Dose (%) 86.4 89.2 87.6 89.8 87 89.3 86 89.6 87.3 87.9 87.7 89.9OAR Mean Dose (%) 71 77.3 74.3 76.3 73.2 75.4 73 75.3 72.8 74.4 73.9 75.7CI 1.16 1 1.08 0.98 1 0.98 1.08 0.97 1.02 0.959 1.06 0.99QI 0.98 0.94 0.94 0.92 0.94 0.9 0.9 0.88 0.9 0.959 0.91 0.89HI 1.08 1.1 1.09 1.11 1.09 1.1 1.1 1.12 1.1 1.11 1.1 1.1Plan MU 569 552 587 528 561 539 559 546 487 481 585 573*PTVD95%Vol. (%) 97.21 94.4 96.24 93.2 96.2 93.5 96.02 92.91 95.47 93.1 95.64 93.91*OARD100%Vol. (%) 39.9 48.59 42.61 46.67 43.2 46.2 41.83 39.92 38.76 39.02 43.02 45.23*OARD90%Vol. (%) 55.65 66.18 61.8 63.2 60.43 62.32 58.63 61.23 56.94 59.08 60.23 62.31*OARD80%Vol. (%) 61.7 71.68 68.12 68.7 65.5 67.9 64.32 66.74 63.91 65.43 66.89 68.04*OARD50%Vol. (%) 73.96 79.74 76.97 79.58 75.52 78.39 75.77 78.8 76.42 78.1 76.49 78.88
Note: *PTVD95%Vol, *OARD100%Vol, *OAR90%Vol, *OAR80%Vol and *OAR50%Vol mean dose received to 95%, 100%, 90%, 80% and50% volume of PTV and OAR respectively. % sign indicates table values are given in % dose of prescribe dose of theirrespective plan; CI = Conformity Index; QI = Quality Index; HI = Homogeneity Index.
Figure 7: Showing the DVH comparison of 6 MV Rapid-arcplan with PO against PRO. Figure 8: DVH comparison of 6 MVFFF Rapid-arc plan withPO against PRO.
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Table 4: Estimate parameter of 15 MV energy IMRT and Rapid-Arc plan with PO versus DVO and PRO, respectively, over thedistinct phantom study sets (PSS).Study-Sets PSS1 PSS2 PSS3 PSS4 PSS5 PSS6IMRT-Parameter PO DVO PO DVO PO DVO PO DVO PO DVO PO DVOPTV Min Dose (%) 92.2 90.1 92.3 90.1 91.6 89.9 92.3 90.2 92 89.6 92.3 90.3PTV Max Dose (%) 102 102.1 102.1 102.3 102 102.2 101.9 102.2 102 102.2 102 102.7PTV Mean Dose (%) 101.8 101.7 101.9 101.7 101.8 101.7 101.6 101.7 101.8 101.7 101.9 101.7OAR Max Dose (%) 82.6 82.1 82.5 82.1 83.6 82.1 82.6 81.1 82.5 82.2 82.6 82OAR Mean Dose (%) 75 74.2 74.7 74 74.9 74.2 75 74.2 74 72.7 75 74.4CI 1.34 1.09 1.35 1.09 1.34 1.09 1.34 1.09 1.3 1.07 1.363 1.10QI 0.99 0.98 0.98 0.97 0.989 0.978 0.989 0.984 0.989 0.984 0.989 0.984HI 1.06 1.07 1.071 1.072 1.069 1.072 1.06 1.07 1.06 1.07 1.06 1.07Plan MU 630 665 624 660 633 667 623 657 602 630 637 977*PTVD95%Vol. (%) 98.21 97.56 98.08 97.5 98.21 97.55 98.19 97.56 98.19 97.47 98.2 97.6*OARD100%Vol. (%) 62.6 56.92 62.53 56.87 61.94 56.79 62.82 56.90 60.74 52.84 63.76 57.75*OARD90%Vol. (%) 71.82 70.32 71.38 70.12 71.68 70.21 71.87 70.35 70.46 66.55 71.95 70.92*OARD80%Vol. (%) 72.47 71.47 72.09 71.07 72.38 71.39 72.48 71.50 71.33 69.45 72.59 71.67*OARD50%Vol. (%) 74.35 73.65 74.15 73.38 74.28 73.59 74.35 73.67 73.36 72.31 74.42 73.65RapidArc Parameter PO PRO PO PRO PO PRO PO PRO PO PRO PO PROPTV Min Dose (%) 89.5 85.1 89.7 87.7 85.7 82.8 84.5 82 83.1 83.9 84.3 83PTV Max Dose (%) 105.1 105.5 104.9 105.8 106.4 106.8 106.1 107.1 105.1 106.9 105.9 106.4PTV Mean Dose (%) 100.3 100.4 100.3 100.4 100.5 100.5 100.4 100.5 100.4 100.6 100.4 100.5OAR Max Dose (%) 87 88.5 86 87.4 86.5 88.7 87.2 89.8 86.9 87.9 86.4 88.3OAR Mean Dose (%) 73.2 73.7 72.6 74.8 75.5 76 72.8 74.8 71.7 72.5 74.9 75.2CI 1.11 1.04 1.13 1.04 1 0.96 1.07 0.97 1.03 0.965 1.08 1QI 0.957 0.95 0.97 0.95 0.92 0.90 0.93 0.88 0.915 0.90 0.905 0.89HI 1.092 1.097 1.09 1.1 1.09 1.1 1.09 1.11 1.1 1.11 1.08 1.1Plan MU 407 386 416 395 394 372 414 383 379 353 425 420*PTVD95%Vol. (%) 96.46 95.04 96.8 95.67 95.46 93.21 96.17 93.83 95.39 93.9 97.78 94.44*OARD100%Vol. (%) 48.8 47.20 48.16 45.88 46.52 43.05 41.55 48.13 44.04 44.66 47.20 47.46*OARD90%Vol. (%) 61.10 60.46 58.94 61.55 64.51 63.83 59.39 60.24 56.63 55.39 63.09 61.72*OARD80%Vol. (%) 66.4 65.63 66.16 66.71 69.32 68.61 64.69 66.30 62.55 61.57 68.24 67.12*OARD50%Vol. (%) 74.9 67.44 75.19 77.78 77.54 78.62 75 78.04 74.27 76.28 77.20 78.33
Note: *PTVD95%Vol, *OARD100%Vol, *OAR90%Vol, *OAR80%Vol and *OAR50%Vol mean dose received to 95%, 100%, 90%, 80% and50%  volume of PTV and OAR respectively. % sign indicates table values are given in % dose of prescribe dose of theirrespective plan; CI = Conformity Index; QI = Quality Index; HI = Homogeneity Index
Figure 9: DVH comparison of 15 MV Rapid-arc plan with PO against PRO.
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Table 5: Average percentage difference for Rapid-Arc Plan parameters between PO and PRO.Parameters 6MV 6MVFFF 15MV % AveragePTV Min Dose (%) 4.11 3.97 2.06 3.38PTV Max Dose (%) 1.45 1.45 0.66 1.18PTV Mean Dose (%) 0.33 0.13 0.1 0.19OAR Max Dose (%) 1.75 2.2 1.33 1.76OAR Mean Dose (%) 3.62 2.7 2.14 2.82CI (%) 8.88 9.15 6.31 8.11QI (%) 3.3 2.79 2.25 2.78HI (%) 1.37 1.57 0.9 1.28Plan MU 22.16 21.5 16.02 20*PTVD95% Vol. (%) 1.88 2.76 2.06 2.33*OARD100%Vol. (%) 14.51 8.06 5.52 9.36*OARD90%Vol. (%) 8.67 5.99 2.05 5.57*OARD80%Vol. (%) 7.03 4.77 2.02 4.6*OARD50%Vol. (%) 5.54 4.05 3.81 4.46Note: *PTVD95%Vol, *OARD100%Vol,*OARD90%Vol, *OAR80%Vol,*OARD50%Vol mean dose received to 95%, 100%, 90%, 80% and 50%volume of PTV and OAR respectively. All the table values are given in % difference between PO and PRO; CI = ConformityIndex; QI = Quality Index; HI = Homogeneity Index
4. DiscussionThe purpose of this study was to present the efficiencyand accuracy of different optimizers used for IMRT andRapid-arc/VMAT technique in Eclipse TPS. From theresult of several IMRT and Rapid-arc/VMAT plans overdistinct energy and a distinct PSS, the behavior of POversus DVO and PRO can be explained quantitatively andqualitatively. Quantitative analysis of newlyincorporated optimizer PO against DVO and PRO forIMRT and Rapid-arc/VMAT respectively, is shown inTables 2, 3, and 4. PO is based upon same principle asDVO and PRO. PO still uses a MRDC dose calculationalgorithm during optimization to speed up dosecalculation. Nevertheless, changes were observedbetween PO versus DVO and PRO. This can bepredominantly explained with the help of fundamentalchange made in PO optimizer. In DVO and PRO, everystructure is represented by its own point cloud and doseis calculated for every dose point of each structure,whereas, in PO whole patient is replaced by a pointcloud with single fixed 3D grid size. This grid sizedecides the size of the voxel as well as a number of voxelwithin each contour for DVO and PRO plan optimization.Point cloud principle provides more degrees of freedomfor the DVO and PRO optimizer whereas, less in the PO.Optimization algorithm and dose calculation enginecalculate dose for each of voxel in contour. It is veryimportant to understand the concept of dose point.The number of dose point, i.e., number voxel generatedinside contour with DVO, PRO, and PO optimizer basedon the principle of point clouding with same grid spacingare different. Accuracy of calculated maximum,minimum, and mean doses are function of the number ofdose point inside the contour. Higher the number ofdose points, more accurate is dose calculation.Consequently, variation in values of these parameterswere observed due to the number of dose points incontour. Grid size automatically defines for DVO andPRO optimizer at time of optimization in optimization
window depending on the volume of contour, e.g., largervolume structures like body, bowel, and bladder definehigh grid size. Whereas, smaller volume structures likeoptic nerve, chiasm, and cochlea define smaller grid size.Additionally, user can define grid size manually in theoptimization window. These optimizers defineincreased number of dose points (i.e. number of voxel)at the periphery of contour than at the center. However,in case of PO, only one grid size can be defined manually,and no liberty  has been provided at the user endindividually as per structure. Major differences werefound in maximum, minimum, and mean dose for PTVand OAR due to the dose calculation strategies ofoptimizer dealing with point cloud distinctly in PO, DVO,and PRO. Also, one of major influential factors is thatDVO does not taken into account for air cavity correctionwhereas, PO and PRO both take into accounts for aircavity correction during plan optimization. This causesvariation in plan quality parameter differently in POversus DVO and PRO. DVO is subjected to optimizationconversance error (OCEs).12-15 All of the DVO, PRO, andPO fast optimizer cause OCEs, and errors are basicallydue to dose calculation in buildup region, dosecalculation for lateral scatter and modeling oftransmission.9 It has been observed that OCEs behaviorsare different for each of DVO, PRO, and PO. Intermediatedose calculation option is introduced in recent version inorder to improve OCEs. However, quantification andnullification of this error are still difficult. DVO optimizerwas found more inconsistent and shows the formerbehavior compared to PO and PRO. This yields variationin the estimated parameters, and variations were foundmore in IMRT plan optimized between PO versus DVOthan the Rapid-arc/VMAT plan optimized with POversus PRO.Qualitative investigation of DVO, PRO, and PO optimizerwas performed based on estimated parameters such asCI, QI, HI, total plan MU, and time taken by optimizer tooptimize the plan. Calculated values of CI indicate that
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conformity in planned optimized with DVO and PRO ismarginally better than the planned optimized with thePO. This indicates that DVO and PRO produced moreconformal plan comparative to PO. In contrary, values ofQI stipulate PO produced a better quality of treatmentplan comparative  to DVO and PRO, i.e. PO producedplan with better coverage to the target volume. Thisleads to the spillage of small-scale prescription dosearound the PTV in the plan optimized with PO than DVOand PRO. Insignificant differences were found in valuesof HI between PO versus DVO and PRO for IMRT andRapid-arc/VMAT plans, respectively. All these threeoptimizers taken into account for the inhomogeneitycorrection; however each optimizer deals withinhomogeneity correction very distinctly, thus leadingto variation in integral planned MU in plan optimizedwith PO versus DVO and PRO for both IMRT andRapid-arc/VMAT plans, respectively. PO generates lessersegment for static segmented IMRT as well as smartdynamic sliding window for Rapid-arc/VMAT comparedto DVO and PRO, respectively. PO produced a betterquality IMRT plan with less number of MU than DVO,whereas in Rapid-arc/VMAT PO produced the plan withslightly higher number of MU than PRO. Similarly, POtakes less time to optimize the plan than DVO and PRO.Quality of the plan can be estimated from the DVH,which provides graphical representation of volumeversus dose. Figures 4, 5, and 6 show the DVHcomparison between two different IMRT plansoptimized with PO versus DVO for 6 MV, 6 MVFFF and15 MV, respectively. These figures were selected basedon average variation found over the distinct PSS andenergy for IMRT and Rapid-arc/VMAT. The DHV shownin these figures indicate a major variation of dosereceived by volume between two different plansoptimized with PO and DVO. Similarly, Figures 7, 8, and9 show the DVH comparison between two differentRapid-arc/VMAT plans optimized with PO versus PROfor 6 MV, 6 MVFFF and 15 MV, respectively. Figures 4, 5,and 6 for IMRT plan show that the variation in the DVHover the PTV were found negligible. Both the DVH ofplan optimized with the PO and DVO are almostoverlapping. However, meaningful deviation were foundtowards the OAR side. In Figures 7, 8 and 9 forRapid-arc/VMAT plan, it was observed that the DVHover both of the PTV and OARs showing meaningfuldeviation between plans optimized with PO and PRO.The limitation of the proposed study is that the studywas carried out with virtual phantom rather than on realpatient CT images. Evaluation of the actual clinicalimpact of optimizer can be further investigated byperforming treatment planning on the CT images of realcancer patients.
5. ConclusionThis study was conducted for an evaluation of newlyincorporated optimizer PO against DVO and PRO for
IMRT and Rapid-arc/VMAT plans, respectively. Selectionof the optimization algorithm during IMRT andRapid-arc/VMAT plan determines plan efficiency,accuracy, and optimal final dose distribution. The CI, QI,HI, integral planned MU, optimized time, and otherdosimetric results obtained using optimizer PO wasfound to be more consistent and accurate than usingDVO and PRO. The results presented in this studyshowed that PO generates plans with better quality inshorter time compared to DVO and PRO for both IMRTand Rapid-arc/VMAT, respectively.
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